- Home
- COLL vs WTTR Comparison
COLL vs WTTR Comparison
Compare COLL & WTTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- WTTR
- Stock Information
- Founded
- COLL 2002
- WTTR 2016
- Country
- COLL United States
- WTTR United States
- Employees
- COLL N/A
- WTTR N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- WTTR Oilfield Services/Equipment
- Sector
- COLL Health Care
- WTTR Energy
- Exchange
- COLL Nasdaq
- WTTR Nasdaq
- Market Cap
- COLL 1.1B
- WTTR 1.1B
- IPO Year
- COLL 2015
- WTTR 2017
- Fundamental
- Price
- COLL $35.95
- WTTR $11.89
- Analyst Decision
- COLL Strong Buy
- WTTR Strong Buy
- Analyst Count
- COLL 4
- WTTR 3
- Target Price
- COLL $44.25
- WTTR $15.00
- AVG Volume (30 Days)
- COLL 311.7K
- WTTR 1.1M
- Earning Date
- COLL 11-06-2025
- WTTR 11-04-2025
- Dividend Yield
- COLL N/A
- WTTR 2.35%
- EPS Growth
- COLL N/A
- WTTR N/A
- EPS
- COLL 1.06
- WTTR 0.32
- Revenue
- COLL $707,007,000.00
- WTTR $1,458,995,000.00
- Revenue This Year
- COLL $21.29
- WTTR N/A
- Revenue Next Year
- COLL $3.36
- WTTR N/A
- P/E Ratio
- COLL $34.09
- WTTR $36.89
- Revenue Growth
- COLL 22.61
- WTTR N/A
- 52 Week Low
- COLL $23.23
- WTTR $7.20
- 52 Week High
- COLL $39.95
- WTTR $15.14
- Technical
- Relative Strength Index (RSI)
- COLL 59.69
- WTTR 63.34
- Support Level
- COLL $33.89
- WTTR $11.38
- Resistance Level
- COLL $35.90
- WTTR $12.01
- Average True Range (ATR)
- COLL 1.05
- WTTR 0.53
- MACD
- COLL 0.27
- WTTR 0.00
- Stochastic Oscillator
- COLL 89.72
- WTTR 92.31
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About WTTR Select Water Solutions Inc.
Select Water Solutions Inc provides sustainable water and chemical solutions to the energy industry. These solutions are supported by the company's critical water infrastructure assets, chemical manufacturing, and water treatment and recycling capabilities. Its reportable segments are Water Services, Water Infrastructure and Chemical Technologies. It generates the majority of its revenue from Water Services segment.